Biologically active taxane analogs and methods of treatment by oral administration Grant US-11873308-B2 United States of America 16 Jan 2024
Taxane analogs for the treatment of brain cancer Grant US-11786504-B2 United States of America 17 Oct 2023
Biologically active taxane analogs and methods of treatment by oral administration Grant US-11220512-B2 United States of America 11 Jan 2022
Taxane analogs for the treatment of brain cancer Grant US-11147793-B2 United States of America 19 Oct 2021
Biologically active taxane analogs and methods of treatment by oral administration Grant US-10745408-B2 United States of America 18 Aug 2020
9,10-α,α-OH-taxane analogs and methods for production thereof Grant US-10639293-B2 United States of America 05 May 2020
Biologically active taxane analogs and methods of treatment by oral administration Grant US-10450323-B2 United States of America 22 Oct 2019
9,10-α,α-OH-taxane analogs and methods for production thereof Grant US-10238621-B2 United States of America 26 Mar 2019
Taxane analogs for the treatment of brain cancer Application US-10143677-B2 United States of America 04 Dec 2018
9, 10-α, α-oh-taxane analogs and methods for production thereof Grant US-9820962-B2 United States of America 21 Nov 2017
Biologically active taxane analogs and methods of treatment by oral administration Grant US-9802951-B2 United States of America 31 Oct 2017
Taxane analogs for the treatment of brain cancer Grant US-9616043-B2 United States of America 11 Apr 2017
9,10-α, α-OH-taxane analogs and methods for production thereof Grant US-9402824-B2 United States of America 02 Aug 2016
Taxane analogs for the treatment of brain cancer Grant US-9132118-B2 United States of America 15 Sep 2015
9, 10-α, α-OH-taxane analogs and methods for production thereof Grant US-8962870-B2 United States of America 24 Feb 2015
Taxane analogs for the treatment of brain cancer Grant US-8409574-B2 United States of America 02 Apr 2013
Biologically active taxane analogs and methods of treatment by oral administration Grant US-8273789-B2 United States of America 25 Sep 2012